First do no harm People at high risk for all adverse effects, whether cardiovascular, gastrointestinal, or renal, should avoid using a Non-steroidal anti-inflammatory drug (NSAID) if possible. Any NSAID use in these people should be at the lowest effective dose for the shortest possible duration, to minimise such risk. Diclofenac (Voltaren, Glaxo-Smith Kline in Australia), … Continue reading Non-steroidal Anti-Inflammatory Drugs (NSAIDs): Risk vs Reward